Clinical Trial Update: Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is testing maintenance olaparib versus observation after adjuvant chemoradiation in patients with p53abn Endometrial cancer and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Endometrial Cancer, p53abn | Phase 3 | Status: RECRUITING